Literature DB >> 26273737

The Role of Long Intergenic Noncoding RNA p21 in Vascular Endothelial Cells.

Chao He1, Jia-Wang Ding1, Song Li1, Hui Wu1, Yu-Rong Jiang1, Wei Yang1, Lin Teng1, Jun Yang1, Jian Yang1.   

Abstract

Large intergenic long noncoding RNA p21 (lincRNA-p21) has recently shown to play an important role in biological functions. However, the biological role of lincRNA-p21 in vascular endothelial cells remains unclear. In the present study, we investigated the role of lincRNA-p21 in vascular endothelial cells through gain- and loss-of-function studies and found that lincRNA-p21 promoted cell apoptosis and induced cell cycle progression. Furthermore, lincRNA-p21 acted as an endogenous sponge by directly binding to miR-130b and decreased miR-130b expression. In addition, miR-130b reversed the inhibitory effect of lincRNA-p21 on the growth of vascular endothelial cells. Taken together, our data highlight the pivotal role of lincRNA-p21 in the growth of vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26273737     DOI: 10.1089/dna.2015.2966

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  13 in total

1.  Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression.

Authors:  Wen-Qin Zhou; Peng Wang; Qiu-Ping Shao; Jian Wang
Journal:  Mol Cell Biochem       Date:  2016-07-08       Impact factor: 3.396

2.  SMILR Aggravates the Progression of Atherosclerosis by Sponging miR-10b-3p to Regulate KLF5 Expression.

Authors:  Huaqing Li; Zhiyu Pan; Qian Chen; Zhen Yang; Dongbing Zhang
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 3.  LncRNAs in vascular biology and disease.

Authors:  Viorel Simion; Stefan Haemmig; Mark W Feinberg
Journal:  Vascul Pharmacol       Date:  2018-02-06       Impact factor: 5.773

Review 4.  The role of lincRNA-p21 in regulating the biology of cancer cells.

Authors:  Yan Huang; Qian Yi; Jianguo Feng; Wei Xie; Wei Sun; Weichao Sun
Journal:  Hum Cell       Date:  2022-08-15       Impact factor: 4.374

5.  Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.

Authors:  Zhen Zhang; Wei Gao; Qing-Qing Long; Jian Zhang; Ya-Fei Li; Dong-Chen Liu; Jian-Jun Yan; Zhi-Jian Yang; Lian-Sheng Wang
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

Review 6.  Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications.

Authors:  Leonardo Elia; Manuela Quintavalle
Journal:  Front Cardiovasc Med       Date:  2017-04-27

7.  Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.

Authors:  Jingying Hou; Lingyun Wang; Quanhua Wu; Guanghui Zheng; Huibao Long; Hao Wu; Changqing Zhou; Tianzhu Guo; Tingting Zhong; Lei Wang; Xuxiang Chen; Tong Wang
Journal:  Stem Cell Res Ther       Date:  2018-04-19       Impact factor: 6.832

8.  miR-103 promotes endothelial maladaptation by targeting lncWDR59.

Authors:  Lucia Natarelli; Claudia Geißler; Gergely Csaba; Yuanyuan Wei; Mengyu Zhu; Andrea di Francesco; Petra Hartmann; Ralf Zimmer; Andreas Schober
Journal:  Nat Commun       Date:  2018-07-06       Impact factor: 14.919

Review 9.  Long Noncoding RNA: Recent Updates in Atherosclerosis.

Authors:  Hao Li; Hongming Zhu; Junbo Ge
Journal:  Int J Biol Sci       Date:  2016-06-07       Impact factor: 6.580

Review 10.  Long Non-coding RNAs in Endothelial Biology.

Authors:  Tyler Weirick; Giuseppe Militello; Shizuka Uchida
Journal:  Front Physiol       Date:  2018-05-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.